What strategies can be used to taper ixekizumab in patients with sustained remission?

Featuring Joel Gelfand, MD, MSCE, FAAD | Penn MedicineDirector, Psoriasis and Phototherapy Treatment CenterDirector, Center for Clinical Sciences in DermatologyPhiladelphia, Pennsylvania | Published November 01, 2024